Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort study

Front Public Health. 2024 Aug 12:12:1385426. doi: 10.3389/fpubh.2024.1385426. eCollection 2024.

Abstract

Background: The Canadian National Vaccine Safety (CANVAS) network conducted a multi-center, prospective vaccine safety study to collect safety data after dose 1 and 2 of COVID-19 vaccines and follow up safety information 7 months after dose 1.

Objective: This study aimed to describe and evaluate the recruitment methods used by CANVAS and the retention of participants by each modality.

Methods: CANVAS deployed a multi-pronged recruitment approach to reach a larger sample, without in-person recruitment. Three primary recruitment strategies were used: passive recruitment, technology-assisted electronic invitation through the vaccine booking system (auto-invitation), or auto-registration through the vaccine registries (auto-enrollment).

Results: Between December 2020 and April 2022, approximately 1.3 million vaccinated adults either self-enrolled or were auto-enrolled in CANVAS, representing about 5% of the vaccinated adult Canadian population. Approximately 1 million participants were auto-enrolled, 300,000 were recruited by auto-invitation, and 5,000 via passive recruitment. Overall survey completion rates for dose 1, dose 2 and the 7-month follow-up surveys were 51.7% (681,198 of 1,318,838), 54.3% (369,552 of 681,198), and 66.4% (452,076 of 681,198), respectively. Completion rates were lower among auto-enrolled participants compared to passively recruited or auto-invited participants who self-enrolled. However, auto-enrolled samples were much larger, which offset the lower completion rates.

Conclusion: Our data suggest that auto-enrollment provided an opportunity to reach and retain a larger number of individuals in the study compared to other recruitment modalities.

Keywords: COVID-19 vaccines; auto-enrollment; auto-invitation; technology-assisted active recruitment; vaccine safety.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19* / prevention & control
  • Canada
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Selection*
  • Prospective Studies
  • SARS-CoV-2
  • Vaccination / statistics & numerical data

Substances

  • COVID-19 Vaccines

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This CANVAS surveillance for COVID-19 vaccines was supported by the COVID-19 Vaccine Readiness funding from the Canadian Institutes of Health Research and the Public Health Agency of Canada CANVAS grant number CVV-450980. It was also supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference group and the COVID-19 Immunity Task Force. PS was supported by a Doctoral Studentship Award from BC Children’s Hospital Research Institute and CIRN Trainee Award. MS was supported via salary awards from the BC Children’s Hospital Foundation and Michael Smith Health Research BC.